Assessment of the use of the speculum for intravitreal injections of anti-VEGF

Acta Ophthalmologica

Volumn 91, Issue 3, 2013, Pages e244-e246

  Méndez, Pablo Carnota ^a   Vázquez, Carlos Méndez ^a   Villar, Jaime Otero ^a   Pazos, José Antonio Saavedra ^a  

^a Centro de Ojos de La Coruña   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

AGED; CLINICAL ARTICLE; COMPLICATION; CONJUNCTIVAL HEMORRHAGE; DRUG REFLUX; ENDOPHTHALMITIS; EYE DISCOMFORT; FEMALE; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; LETTER; MALE; MEDICAL DEVICE; PAIN ASSESSMENT; PATIENT COMFORT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPECULUM;

EID: 84876406205     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2012.02551.x     Document Type: Letter

References (5)

1. Ferguson AW, Scott JA, McGavigan J, Elton RA, McLean J, Schmidt U, Kelkar R, &, Dhillon B, (2003): Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study. Br J Ophthalmol 87: 163-167.
2. Frenkel RE, Haji SA, La M, Frenkel MP, &, Reyes A, (2010): A protocol for the retina surgeon's safe initial intravitreal injections. Clin Ophthalmol 10: 1279-1285.
3. Green-Simms AE, Ekdawi NS, &, Bakri SJ, (2011): Survey of intravitreal injection techniques among retinal specialists in the United States. Am J Ophthalmol 151: 329-332.
4. Jager RD, Aiello LP, Patel SC, &, Cunningham ET Jr, (2004): Risks of intravitreous injection: a comprehensive review. Retina 24: 676-698.
5. Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA, & Post-Injection Endophthalmitis (PIE) Study Team (2011): Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology 118: 2028-2034.